Radiometal-labeled peptide-PNA conjugates for targeting bcl-2 expression: Preparation, characterization, and in vitro mRNA binding

Bioconjugate Chemistry

Volumn 13, Issue 6, 2002, Pages 1176-1180

  Lewis, Michael R ^a,b,c   Jia, Fang ^b   Gallazzi, Fabio ^b   Wang, Yi ^b   Zhang, Jiuli ^b   Shenoy, Nalini ^b   Lever, Susan Z ^b   Hannink, Mark ^c  

^a UNIVERSITY OF MISSOURI   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACIDS; OLIGONUCLEOTIDES; SYNTHESIS (CHEMICAL);

ANTISENSE PEPTIDES; BCL-2 GENE; CELL-FREE SYSTEM; IN-VITRO; MRNA BINDING; PEPTIDE NUCLEIC ACID; SOLID PHASIS; SOLID-PHASE; SYNTHESISED; TETRAACETIC ACID;

PEPTIDES;

ANTINEOPLASTIC AGENT; INDIUM; MESSENGER RNA; PEPTIDE; PEPTIDE NUCLEIC ACID; YTTRIUM;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PROTO ONCOGENE; SYNTHESIS;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; DRUG DELIVERY SYSTEMS; DRUG DESIGN; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; INDIUM RADIOISOTOPES; PEPTIDE NUCLEIC ACIDS; PEPTIDES; RNA, MESSENGER; YTTRIUM RADIOISOTOPES;

EID: 0036859952     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc025591s     Document Type: Article

References (44)

1. Tsujimoto, Y., Finger, L. R., Yunis, J., Nowell, P. C., and Croce, C. M. (1984) Cloning of the chromosome breakpoint of neoplastic B cells with the t(14; 18) chromosome translocation. Science 226, 1097-1099.
2. Hockenbery, D., Nuñez, G., Milliman, C., Schreiber, R. D., and Korsmeyer, S. J. (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348, 334-336.
3. Sentman, C. L., Shutter, J. R., Hockenbery, D., Kanagawa, O, and Korsmeyer, S. J. (1991) Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67, 879-888.
4. Strasser, A., Harris, A. W., and Cory, S. (1991) Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67, 889-899.
5. Mirkovic, N., Voehringer, D. W., Story, M. D., McConkey, D. J., McDonnell, T. J., and Meyn, R. E. (1997) Resistance to radiation-induced apoptosis in Bcl-2-expressing cells is reversed by depleting cellular thiols. Oncogene 15, 1461-1470.
6. Miyashita, T., and Reed, J. C. (1992) Bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 Lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res. 52, 5407-5411.
7. Miyashita, T., and Reed, J. C. (1993) Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81, 151-157.
8. Reed, J. C., Kitada, S., Takayama, S., and Miyashita, T. (1994) Regulation of chemoresistance by the bcl-2 oncoprotein in non-Hodgkin's lymphoma and lymphocytic leukemia cell lines. Ann. Oncol. 5, S61-S65.
9. Yunis, J. J., Oken, M. M., Kaplan, M. E., Ensrud, K. M., Howe, R. R., and Theologides, A. (1982) Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. N. Engl. J. Med. 307, 1231-1236.
10. Tsujimoto, Y., Cossman, J., Jaffe, E., and Croce, C. M. (1985) Involvement of the bcl-2 gene in human follicular lymphoma. Science 228, 1440-1443.
11. Levine, E. G., Arthur, D. C., Frizzera, G., Peterson, B. A., Hurd, D. D., and Bloomfield, C. D. (1985) There are differences in cytogenetic abnormalities among histologic subtypes of the non-Hodgkin's lymphomas. Blood 66, 1414-1422.
12. Pezzella, F., Tse, A. G. D., Cordell, J. L., Pulford, K. A. F., Gatter, K. C., and Mason, D. Y. (1990) Expression of the bcl-2 oncogene protein is not specific for the 14; 18 chromosomal translocation. Am. J. Pathol. 137, 225-232.
13. Zutter, M., Hockenbery, D., Silverman, G. A., and Korsmeyer, S. J. (1991) Immunolocalization of the bcl-2 protein within hematopoietic neoplasms. Blood 78, 1062-1068.
14. Lanzafame, S., Emmanuele, C., Torrisi, A., and Magro, G. (1998) Correlated expression of BCL-2 protein, estrogen receptor, cathepsin D and low growth fraction (PCNA) in intracystic papillary breast carcinoma. Pathol. Res. Pract. 194, 541-547.
15. Pezzella, F., Turley, H., Kuzu, I., Tungekar, M. F., Dunnill, M. S., Pierce, C. B., Harris, A., Gatter, K. C., and Mason, D. Y. (1993) Bcl-2 protein in non-small-cell lung carcinoma. N. Engl. J. Med. 329, 690-694.
16. Jiang, S.-X., Sato, Y., Kuwao, S., and Kameya, T. (1995) Expression of bcl-2 oncogene protein is prevalent in small cell lung carcinomas. J. Pathol. 177, 135-138.
17. Sinicrope, F. A., Ruan, S. B., Cleary, K. R., Stephens, L. C., Lee, J. J., and Levin, B. (1995) Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res. 55, 237-241.
18. Yang, H.-B., Chow, N.-H., Sheu, B.-S., Chan, S.-H., Chien, C.-H., and Su, I.-J. (1999) The role of bcl-2 in the progression of the colorectal adenoma-carcinoma sequence. Anticancer Res. 19, 727-730.
19. Colombel, M., Symmans, F., Gil, S., O'Toole, K. M., Chopin, D., Benson, M., Olsson, C. A., Korsmeyer, S., and Buttyan, R. (1993) Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Am. J. Pathol. 143, 390-400.
20. Sullivan, G. F., Amenta, P. S., Villanueva, J. D., Alvarez, C. J., Yang, J.-M., and Hait, W. N. (1998) The expression of drug resistance gene products during the progression of human prostate cancer. Clin. Cancer Res. 4, 1393-1403.
21. Wang, D.-G., Johnston, C. F., and Buchanan, K. D. (1997) Oncogene Expression in Gastroenteropancreatic Neuroendocrine Tumors. Implications for Pathogenesis. Cancer 80, 668-675.
22. Cerroni, L., Soyer, H. P., and Kerl, H. (1995) Bcl-2 protein expression in cutaneous malignant melanoma and benign melanocytic nevi. Am. J. Dermatopathol. 17, 7-11.
23. Karakas, T., Maurer, U., Weidmann, E., Miething, C. C., Hoelzer, D., and Bergmann, L. (1998) High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemia. Ann. Oncol. 9, 159-165.
24. Puthier, D., Pellat-Deceunynck, C., Barillé, S., Robillard, N., Rapp, M.-J., Juge-Morineau, N., Harousseau, J.-L., Bataille, R., and Amiot, M. (1999) Differential expression of bcl-2 in human plasma cell disorders according to proliferation status and malignancy. Leukemia 13, 289-294.
25. Fisher, R. I. (1997) Cyclophosphamide, doxorubicin, vincristine, and prednisone versus intensive chemotherapy in non-Hodgkin's lymphoma. Caner Chemother. Pharmacol. 40 (Suppl), S42-S46.
26. Hermine, O., Haioun, C., Lepage, E., d'Agay, M.-F., Briere, J., Lavignac, C., Fillet, G., Salles, G., Marolleau, J.-P., Diebold, J., Reyes, F., and Gaulard, P. (1996) Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Blood 87, 265-272.
27. Hill, M. E., MacLennan, K. A., Cunningham, D. C., Vaughan Hudson, B., Burke, M., Clarke, P., Di Stefano, F., Anderson, L., Vaughan Hudson, G., Mason, D., Selby, P., and Linch, D. C. (1996) Prognostic significance of bcl-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: A british national lymphoma investigation study. blood 88, 1046-1051.
28. Nielsen, P. E., Egholm, M., Berg, R. H., and Buchardt, O. (1991) Sequence selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 254, 1497-1500.
29. Larsen, H. J., Bentin, T., and Nielsen, P. E. (1999) Antisense properties of peptide nucleic acid. Biochim. Biophys. Acta 1489, 159-166.
30. Aldrian-Herrada, G., Desarménien, M. G., Orcel, H., Boissin-Agasse, L, Méry, J., Brugidou, J., and Rabié, A. (1998) A peptide nucleic acid (PNA) is more rapidly internalized in cultured neurons when coupled to a retro-inverso delivery peptide. The antisense activity depresses the target mRNA and protein in magnocellular oxytocin neurons. Nucleic Acids Res. 26, 4910-4916.
31. Pooga, M., Soomets, U., Hällbrink, M., Valkna, A., Saar, K., Rezaei, K., Kahl, U., Hao, J.-X., Xu, X.-J., Wiesenfeld-Hallin, Z., Hökfelt, T., Bartfai, T., and Langel, U. (1998) Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat. Biotechnol. 16, 857-861.
32. Derossi, D., Joliot, A. H., Chassaing, G., and Prochiantz, A. (1994) The Third Helix of the Antennapedia Homeodomain Translocates through Biological Membranes. J. Biol. Chem. 269, 10444-10450.
33. Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L. L., Pepinsky, B., and Barsoum, J. (1994) Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. U.S.A. 91, 664-668.
34. Ho, A., Schwarze, S. R., Mermelstein, S. J., Waksman, G, and Dowdy, S. F. (2001) Synthetic protein transduction domains: Enhanced transduction potential in vitro and in vivo. Cancer Res. 61, 474-477.
35. Gallazzi, F., Wang, Y., Jia, F., Shenoy, N., Lever, S. Z., and Lewis, M. R. (2002) Preparation of a radiolabeled peptide-PNA conjugate for imaging oncogene expression. 27th European Peptide Symposium, Sorrento, Italy, Abstract P E21.
36. (b) Gallazzi, F., Wang, Y., Shenoy, N., Lever, S. Z., and Lewis, M. R., manuscript in preparation.
37. Dewanjee, M. K., Ghafouripour, A. K., Kapadvanjwala, M., Dewanjee, S., Serafini, A. N., Lopez, D. M., and Sfakianakis, G. N. (1994) Noninvasive Imaging of c-myc Oncogene Messenger RNA with Indium-111-Antisense Probes in a Mammary Tumor-Bearing Mouse Model. J. Nucl. Med. 35, 1054-1063.
38. Dewanjee, M. K., Haider, N., and Narula, J. (1999) Imaging with radiolabeled antisense oligonucleotides for the detection of intracellular messenger RNA and cardiovascular disease. J. Nucl. Cardiol. 6, 345-356.
39. Snyder, L. R., and Kirkland, J. J. (1979) Size-exclusion chromatography. Introduction to Modern Liquid Chromatography, First Edition, pp 483-540, John Wiley & Sons, Inc., New York.
40. Atkins, P. W. (1982) The structures and properties of macromolecules. Physical Chemistry, Second Edition, p 825, W. H. Freeman and Company, San Francisco.
41. Sambrook, J., and Russell, D. W. (2001) Separation of RNA according to size: Electrophoresis of RNA through agarose gels containing formaldehyde. Molecular Cloning: A Laboratory Manual, 3rd Ed., Vol. 2, pp 7.31-7.34, Cold Spring Harbor, New York.
42. Sambrook, J., and Russell, D. W. (2001) Transfer and fixation of Denatured RNA to membranes. Molecular Cloning: A Laboratory Manual, 3rd Ed., Vol. 2, pp 7.35-7.41, Cold Spring Harbor, New York.
43. Graninger, W. B., Seto, M., Boutain, B., Goldman, P., and Korsmeyer, S. J. (1987) Expression of bcl-2 and bcl-2-ig fusion transcripts in normal and neoplastic cells. J. Clin. Invest. 80, 1512-1515.
44. Seto, M., Jaeger, U., Hockett, R. D., Graninger, W., Bennett, S., Goldman, P., and Korsmeyer, S. J. (1988) Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma. EMBO J. 7, 123-131.